[Dyspnea and ventilator dependence after birth in a full-term female infant]

Zi-Qi Wu1, Jun Xu, Ai-Min Zhang

  • 1Department of Neonatology, Hunan Provincial People's Hospital/ First Affiliated Hospital of Hunan Normal University, Changsha 410005, China. Lilly610@sina.com.

Insights

A rare ABCA3 gene mutation caused severe lung disease in an infant. Early genetic testing is crucial for diagnosing congenital pulmonary surfactant metabolism defects and guiding treatment.

Area of Science:

  • Pediatric Pulmonology
  • Medical Genetics
  • Neonatology

Background:

  • Congenital pulmonary surfactant metabolism defects present significant challenges in neonates.
  • Infantile diffuse pulmonary interstitial disease requires early and accurate diagnosis.

Observation:

  • A 43-day-old female infant presented with persistent respiratory distress, cyanosis, and dyspnea since birth.
  • Lung imaging revealed diffuse ground-glass opacities unresponsive to conventional therapies like antibiotics and mechanical ventilation.

Findings:

  • Genetic testing identified compound heterozygous mutations (c.1890C>A(p.Tyr630Ter)+c.3208G>A(p.Ala1070Thr)) in the ABCA3 gene.
  • Pulmonary pathology confirmed interstitial lung disease, establishing the diagnosis of ABCA3 gene-related infantile diffuse pulmonary interstitial disease.

Implications:

  • This case highlights the importance of considering congenital surfactant defects in neonates with unexplained respiratory failure.
  • Early genetic testing for ABCA3 mutations is vital for prognosis, genetic counseling, and timely intervention.
  • Prompt diagnosis facilitates appropriate management strategies for infants with surfactant metabolism disorders.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.7K
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
485
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
2.1K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
63.6K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
408
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
858